• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Correction to: Challenges and progress of neurodrug: bioactivities, production and delivery strategies of nerve growth factor protein.

作者信息

Zhou Nan, Gu TingWei, Xu Yang, Liu Yuda, Peng LiHua

机构信息

College of Pharmaceutical Sciences, Zhejiang University, 866# Yuhangtang Road, Hangzhou, 310058, China.

State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China.

出版信息

J Biol Eng. 2025 Jul 28;19(1):70. doi: 10.1186/s13036-025-00543-7.

DOI:10.1186/s13036-025-00543-7
PMID:40722039
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12305953/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f31/12305953/845db09b2735/13036_2025_543_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f31/12305953/8d18766278da/13036_2025_543_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f31/12305953/845db09b2735/13036_2025_543_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f31/12305953/8d18766278da/13036_2025_543_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f31/12305953/845db09b2735/13036_2025_543_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f31/12305953/8d18766278da/13036_2025_543_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f31/12305953/845db09b2735/13036_2025_543_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f31/12305953/8d18766278da/13036_2025_543_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f31/12305953/845db09b2735/13036_2025_543_Fig4_HTML.jpg

相似文献

1
Correction to: Challenges and progress of neurodrug: bioactivities, production and delivery strategies of nerve growth factor protein.对《神经药物的挑战与进展：神经生长因子蛋白的生物活性、生产及递送策略》的更正
J Biol Eng. 2025 Jul 28;19(1):70. doi: 10.1186/s13036-025-00543-7.
2
Challenges and progress of neurodrug: bioactivities, production and delivery strategies of nerve growth factor protein.神经药物的挑战与进展：神经生长因子蛋白的生物活性、生产及递送策略
J Biol Eng. 2023 Dec 4;17(1):75. doi: 10.1186/s13036-023-00392-2.
3
Developing a gene therapy for Charcot-Marie-Tooth disease: progress and challenges.开发用于治疗夏科-马里-图思病的基因疗法：进展与挑战。
Regen Med. 2025 Apr 12:1-9. doi: 10.1080/17460751.2025.2491257.
4
Innovative gene delivery systems for retinal disease therapy.用于视网膜疾病治疗的创新基因递送系统。
Neural Regen Res. 2026 Feb 1;21(2):542-552. doi: 10.4103/NRR.NRR-D-24-00797. Epub 2024 Dec 7.
5
Inhalable nucleic acid therapeutics for chronic pulmonary disease: Progress, challenges, and prospects.用于慢性肺病的可吸入核酸疗法：进展、挑战与前景
Acta Biomater. 2025 Jul 31. doi: 10.1016/j.actbio.2025.07.068.
6
Low molecular weight fucoidan: Production methods and their therapeutic applications.低分子量岩藻依聚糖：生产方法及其治疗应用。
Int J Biol Macromol. 2025 Jul;318(Pt 4):145309. doi: 10.1016/j.ijbiomac.2025.145309. Epub 2025 Jun 16.
7
[Advancement in neutrophil-based drug delivery systems].[基于中性粒细胞的药物递送系统的进展]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2025 Jul 4;54(4):479-488. doi: 10.3724/zdxbyxb-2025-0093.
8
Novel drug delivery systems for hirudin-based product development and clinical applications.用于基于水蛭素的产品开发和临床应用的新型药物递送系统。
Int J Biol Macromol. 2025 Jan;287:138533. doi: 10.1016/j.ijbiomac.2024.138533. Epub 2024 Dec 8.
9
Co-delivery of neurotrophic factors and a zinc chelator substantially increases retinal ganglion cell survival and axon protection in the optic nerve crush model.在视神经挤压模型中，神经营养因子与锌螯合剂的共同递送可显著提高视网膜神经节细胞的存活率并保护其轴突。
Acta Biomater. 2025 Jul 1;201:297-308. doi: 10.1016/j.actbio.2025.06.007. Epub 2025 Jun 5.
10
Challenges and strategies for maintaining nutrition services in the Democratic Republic of Congo during COVID-19: a qualitative study.新冠疫情期间刚果民主共和国维持营养服务的挑战与策略：一项定性研究
Front Health Serv. 2025 Jun 24;5:1551131. doi: 10.3389/frhs.2025.1551131. eCollection 2025.

本文引用的文献

1
Potential Therapeutic Usage of Nanomedicine for Glaucoma Treatment.纳米医学在青光眼治疗中的潜在治疗用途。
Int J Nanomedicine. 2020 Aug 6;15:5745-5765. doi: 10.2147/IJN.S254792. eCollection 2020.
2
Innovative Therapy for Alzheimer's Disease-With Focus on Biodelivery of NGF.阿尔茨海默病的创新疗法——聚焦神经生长因子的生物递送
Front Neurosci. 2019 Feb 5;13:38. doi: 10.3389/fnins.2019.00038. eCollection 2019.